A case of pulmonary hypertension associated with myelofibrosis: therapeutical challenges from acute to chronic setting
Anno:
2024
A 85-year-old female was transferred to our ICCU for acute heart failure from one of our spoke hospitals. The patient had a long history of chronic myelofibrosis, treated with fedratinib as a second-line agent after ruxolitinib failure. During a recent hospital admission, transthoracic echocardiography already showed signs of severe…